The Influence of Pharmaceutical Brochures on the Prescribing Habits of Orthopaedic Surgeons in Qatar: A Questionnaire-Based Study — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
The Influence of Pharmaceutical Brochures on the Prescribing Habits of Orthopaedic Surgeons in Qatar: A Questionnaire-Based Study
Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
,
Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
,
Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
,
Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
,
Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
,
Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
,
School of Medicine, University of Greater Manchester, Bolton, UK
1 Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
2 Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
3 Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
4 Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
5 Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
6 Department of Trauma and Orthopaedics, Al Ahli Hospital, Doha, Qatar
7 School of Medicine, University of Greater Manchester, Bolton, UK
Bac kground: Pharmaceutical marketing, including the use of printed brochures, is a common method to promote both new and existing medications. However, its influence on clinical practice, particularly in specialties such as orthopaedics, remains underexplored. Objective: To evaluate whether pharmaceutical brochures affect the prescribing practices of orthopaedic surgeons in Qatar, specifically regarding non-steroidal anti-inflammatory drugs (NSAIDs). Methods: A structured questionnaire was distributed to orthopaedic surgeons practicing in Qatar between January and March 2025. Data on the reception and perceived influence of drug brochures were collected and analyzed. Resu lts: Of 27 surgeons contacted, 22 responded (81%). All respondents reported prescribing NSAIDs. While 90% received pharmaceutical brochures regularly, only 14% reported that these brochures could influence their prescribing habits. The majority either discarded the brochures without reading them or read them and then discarded them immediately. Conclusion: Despite widespread dissemination, pharmaceutical brochures appear to have minimal influence on the prescribing patterns of orthopaedic surgeons in Qatar. Further research is needed to understand the nuances of pharmaceutical marketing and its long-term effects on prescribing behavior.
Fadoul, Y., Haddad, C., Habib, J. and Zoghbi, M. (2022) Pharmaceutical Brochures in Lebanon: Do They Meet WHO Recommendations? BMC Primary Care , 23, Article No. 314. https://doi.org/10.1186/s12875-022-01930-5
Parker, R.S. and Pettijohn, C.E. (2005) Pharmaceutical Drug Marketing Strategies and Tactics: A Comparative Analysis of Attitudes Held by Pharmaceutical Representatives and Physicians. Health Marketing Quarterly , 22, 27-43. https://doi.org/10.1300/j026v22n04_03
Figueiras, A., Caamaño, F. and Gestal-Otero, J.J. (2000) Influence of Physician’s Education, Drug Information and Medical-Care Settings on the Quality of Drugs Prescribed. European Journal of Clinical Pharmacology , 56, 747-753. https://doi.org/10.1007/s002280000217
Cardarelli, R., Licciardone, J.C. and Taylor, L.G. (2006) A Cross-Sectional Evidence-Based Review of Pharmaceutical Promotional Marketing Brochures and Their Underlying Studies: Is What They Tell Us Important and True? BMC Family Practice , 7, Article No. 13. https://doi.org/10.1186/1471-2296-7-13
Lexchin, J. (1993) Physicians and Drug Company Interactions. Canadian Family Physician , 39, 1881-1882.
Hailu, A.D., Workneh, B.D. and Kahissay, M.H. (2021) Influence of Pharmaceutical Marketing Mix Strategies on Physicians’ Prescribing Behaviors in Public and Private Hospitals, Dessie, Ethiopia: A Mixed Study Design. BMC Public Health , 21, Article No. 65. https://doi.org/10.1186/s12889-020-10063-2
Leonardo Alves, T., Lexchin, J. and Mintzes, B. (2019) Medicines Information and the Regulation of the Promotion of Pharmaceuticals. Science and Engineering Ethics , 25, 1167-1192. https://doi.org/10.1007/s11948-018-0041-5
Ahmed, R.R., Vveinhardt, J., Streimikiene, D. and Awais, M. (2016) Mediating and Marketing Factors Influence the Prescription Behavior of Physicians: An Empirical Investigation. Amfiteatru Economic Journal , 18, 153-167.
Sharma, S., Akhoon, N., Moe, H.W., Nair, D.R. and Shashidhar, V. (2021) A Study of Perceptions and Exposure of Drug Promotional Literature among Clinicians in a Teaching Hospital. Perspectives in Clinical Research , 12, 140-145. https://doi.org/10.4103/picr.picr_36_19
Wood, S.F., Podrasky, J., McMonagle, M.A., Raveendran, J., Bysshe, T., Hogenmiller, A., et al . (2017) Influence of Pharmaceutical Marketing on Medicare Prescriptions in the District of Columbia. PLOS ONE , 12, e0186060. https://doi.org/10.1371/journal.pone.0186060
Almasri, M., Bukhari, Y., Alzuair, B., Almadi, M. and Abdulrahman, A. (2020) Ethical Considerations in Doctors & Pharmaceutical Industries Relationship: A Narrative Review. International Journal of Medicine in Developing Countries , 4, 244-252. https://doi.org/10.24911/ijmdc.51-1572794591
Wazana, A. (2000) Physicians and the Pharmaceutical Industry: Is a Gift ever Just a Gift? JAMA , 283, 373-380. https://doi.org/10.1001/jama.283.3.373
Perlis, R.H. and Perlis, C.S. (2016) Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLOS ONE , 11, e0155474. https://doi.org/10.1371/journal.pone.0155474
Ornstein, C., Jones, R.G. and Tigas, M. (2017) Now Theres Proof: Docs Who Get Company Cash Tend to Prescribe More Brand Name Meds. ProPublica.
Sigworth, S.K., Nettleman, M.D. and Cohen, G.M. (2001) Pharmaceutical Branding of Resident Physicians. JAMA : The Journal of the American Medical Association , 286, 1024-1025. https://doi.org/10.1001/jama.286.9.1024-a
Iyer, S., Derman, P. and Sandhu, H.S. (2016) Orthopaedics and the Physician Payments Sunshine Act: An Examination of Payments to U.S. Orthopaedic Surgeons in the Open Payments Database. Journal of Bone and Joint Surgery , 98, e18. https://doi.org/10.2106/jbjs.o.00343
Marshall, D.C., Jackson, M.E. and Hattangadi-Gluth, J.A. (2016) Disclosure of Industry Payments to Physicians: An Epidemiological Analysis of Early Data from the Open Payments Program. Mayo Clinic Proceedings , 91, 84-96. https://doi.org/10.1016/j.mayocp.2015.10.016
Fleischman, W., Ross, J.S., Melnick, E.R., Newman, D.H. and Venkatesh, A.K. (2016) Financial Ties between Emergency Physicians and Industry: Insights from Open Payments Data. Annals of Emergency Medicine , 68, 153-158.E4. https://doi.org/10.1016/j.annemergmed.2016.01.014
Tierney, N.M., Saenz, C., McHale, M., Ward, K. and Plaxe, S. (2016) Industry Payments to Obstetrician-Gynecologists: An Analysis of 2014 Open Payments Data. Obstetrics & Gynecology , 127, 376-382. https://doi.org/10.1097/aog.0000000000001270
Svider, P.F., Bobian, M., Lin, H., Setzen, M., Baredes, S., Eloy, J.A., et al . (2016) Are Industry Financial Ties Associated with Greater Scholarly Impact among Academic Otolaryngologists? The Laryngoscope , 127, 87-94. https://doi.org/10.1002/lary.26027
Parikh, K., Fleischman, W. and Agrawal, S. (2016) Industry Relationships with Pediatricians: Findings from the Open Payments Sunshine Act. Pediatrics , 137, e20154440. https://doi.org/10.1542/peds.2015-4440
Khazzaka, M. (2019) Pharmaceutical Marketing Strategies’ Influence on Physicians’ Prescribing Pattern in Lebanon: Ethics, Gifts, and Samples. BMC Health Services Research , 19, Article No. 80. https://doi.org/10.1186/s12913-019-3887-6
Ibrahim, I.A.Y. and Belanger, C.H. (2015) Pharmaceutical Representatives and Prescription Decisions by Physicians in Saudi Arabia. Journal of Marketing Managem ent , 3, 69-79.
Spiller, L.D. and Wymer, W.W. (2002) Physicians’ Responses to Marketing Strategies of Pharmaceutical Companies. Journal of Pharmaceutical Marketing & Management , 15, 15-30. https://doi.org/10.3109/j058v15n01_04
Al-Areefi, M.A., Hassali, M.A. and b Mohamed Ibrahim, M.I. (2013) Physicians’ Perceptions of Medical Representative Visits in Yemen: A Qualitative Study. BMC Health Services Research , 13, Article No. 331. https://doi.org/10.1186/1472-6963-13-331
Ziegler, M.G., Lew, P. and Singer, B.C. (1995) The Accuracy of Drug Information from Pharmaceutical Sales Representatives. JAMA : The Journal of the Am erican Medical Association , 273, 1296-1298. https://doi.org/10.1001/jama.1995.03520400066047
Chren, M.M. (1999) Interactions between Physicians and Drug Company Representatives. The American Journal of Medicine , 107, 182-183.
Maestri, E., Furlani, G., Suzzi, F., Campomori, A., Formoso, G., et al . (2000) So Much Time for So Little: Italy’s Pharmaceutical Industry and Doctors’ Information Needs. BMJ , 320, 55-55. https://doi.org/10.1136/bmj.320.7226.55
Lexchin, J. (2003) Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review. BMJ , 326, 1167-1170. https://doi.org/10.1136/bmj.326.7400.1167
Vancelik, S., Beyhun, N.E., Acemoglu, H. and Calikoglu, O. (2007) Impact of Pharmaceutical Promotion on Prescribing Decisions of General Practitioners in Eastern Turkey. BMC Public Health , 7, Article No. 122. https://doi.org/10.1186/1471-2458-7-122